rs1555630216
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378183.1(PIEZO2):c.5257-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000722 in 1,384,636 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001378183.1 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Gordon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- arthrogryposis, distal, with impaired proprioception and touchInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
- arthrogryposis- oculomotor limitation-electroretinal anomalies syndromeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- connective tissue disorderInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- Marden-Walker syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIEZO2 | NM_001378183.1 | c.5257-1G>A | splice_acceptor_variant, intron_variant | Intron 38 of 55 | ENST00000674853.1 | NP_001365112.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIEZO2 | ENST00000674853.1 | c.5257-1G>A | splice_acceptor_variant, intron_variant | Intron 38 of 55 | NM_001378183.1 | ENSP00000501957.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.22e-7 AC: 1AN: 1384636Hom.: 0 Cov.: 31 AF XY: 0.00000146 AC XY: 1AN XY: 683230 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The c.5083-1G>A variant in the PIEZO2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This splice site variant destroys the canonical splice acceptor site in intron 35. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.5083-1G>A variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.5083-1G>A as a pathogenic variant. -
Arthrogryposis, distal, with impaired proprioception and touch Pathogenic:1
This splice site mutation is categorized as deleterious according to ACMG guidelines (PMID: 18414213) and was found in trans with another variant (c.1528-1G>A) in a 6-year-old female with ataxia, hypotonia, mild dysmorphic features, delayed motor development, scoliosis. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at